Kv7.2-7.5 voltage-gated potassium channel (KCNQ2-5) opener, retigabine, reduces capsaicin-induced visceral pain in mice.

Article Details

Citation
Copy to clipboard

Hirano K, Kuratani K, Fujiyoshi M, Tashiro N, Hayashi E, Kinoshita M

Kv7.2-7.5 voltage-gated potassium channel (KCNQ2-5) opener, retigabine, reduces capsaicin-induced visceral pain in mice.

Neurosci Lett. 2007 Feb 14;413(2):159-62. Epub 2006 Dec 20.

PubMed ID
17184917 [ View in PubMed
]
Abstract

K(v)7.2-7.5 voltage-gated potassium channels (KCNQ2-5) are associated with M-current and known to distribute in the nociceptive sensory pathway (e.g., dorsal root ganglia and spinal cord). Opening of these channels leads to cell membrane hyperpolarization that results in decreased neuronal action potentials. Since, KCNQ/M-current is located in the visceral sensory system, we examined the anti-nociceptive effect of the KCNQ opener, retigabine, on visceral pain induced by an intracolonic injection of capsaicin in mice. Intraperitoneal administration of retigabine (1, 3 and 10 mg/kg) dose-dependently suppressed visceral pain behavior (i.e., the number of licking) induced by the capsaicin treatment and prolonged the latency to first licking. These data provide the first evidence that increased KCNQ channel conductance plays an inhibitory role in the visceral pain pathway.

DrugBank Data that Cites this Article

Drug Targets
DrugTargetKindOrganismPharmacological ActionActions
EzogabinePotassium voltage-gated channel subfamily KQT member 2ProteinHumans
Unknown
Not AvailableDetails
EzogabinePotassium voltage-gated channel subfamily KQT member 3ProteinHumans
Unknown
Not AvailableDetails
EzogabinePotassium voltage-gated channel subfamily KQT member 4ProteinHumans
Unknown
Not AvailableDetails
EzogabinePotassium voltage-gated channel subfamily KQT member 5ProteinHumans
Unknown
Not AvailableDetails